Multiple genetic factors contribute to susceptibility to rheumatoid arthritis (RA). The extent of variability in disease presentation in RA may be related to genetic heterogeneity. In this study we investigated the association of the TNF gene polymorphism at position +489 with susceptibility to and severity of RA. Analysis of the frequency of the +489 A and G alleles in a group of 293 consecutive RA patients and 138 healthy controls revealed a significant decrease of the A allele. The +489 GA patients had a 3.9 times decreased chance of having erosive disease than +489 GG patients. These results were confirmed in a prospective study using a cohort of 112 patients who were followed for 12 years. The progression rate of the erosion score over 12 years expressed as Sharp score for X-rays of hands and feet was 3.4 per year for the GA-genotyped patients and 12.1 for the GG-genotyped patients. These associations were independent of rheumatoid factor and HLA-shared epitope positivity. In conclusion, these data suggest that the intron TNF +489 polymorphism is associated with susceptibility to and disease severity of RA independently of HLA-shared epitope-positive alleles.
Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder of unknown etiology that affects the synovial membrane of multiple joints. The clinical presentation may vary from mild to severe disease with excessive erosions of periarticular bone leading to loss of functional capacity. Both genetic factors and environmental factors are important in the development of the disease. The genetic contribution to susceptibility for RA is underlined by a three to four-fold higher concordance percentage for clinically expressed disease in monozygotic twins compared to dizygotic twins. [1] [2] [3] The mode of segregation in the population is best explained by a polygenic background influenced by the environmental stimuli. Estimates suggest that 10 different genetic regions may be linked to susceptibility to RA. 4 As a consequence, variability in the contribution of genetic factors involved in disease may be related to heterogeneity in clinical presentation of the disease. Good evidence exists that RA is associated with certain HLA-DRB1 alleles [5] [6] [7] found in DR1, DR4 and DR10 specificities. Parametric linkage analysis suggests that HLA may contribute up to 30% of overall inherited susceptibility to RA. 8 Moreover, evidence exists that HLA-DRB1 alleles may predispose to a more severe course of the disease. 5, 6 The disease-associated alleles share a short sequence, QKRAA, QRRAA and RRRAA present in the peptide-binding groove of the MHC molecule and are named shared-epitope (SE) alleles. 9 However, despite intense research efforts the functional basis of disease-associated HLA alleles in RA is still not understood.
In the hunt for genetic factors that contribute to RA, the tumor necrosis factor (TNF) gene has received considerable attention. The TNF gene is located on chromosome 6 within the MHC class III region between HLA-B and HLA-DR genes. 10 Several lines of evidence suggest a pivotal role of TNF in RA. 11 The most compelling evidence stems from studies wherein a remarkable clinical benefit has been observed in RA patients treated with anti-TNF antibodies. 12 The finding of genetically determined interindividual differences in TNF production by PBMC isolated from healthy individuals may provide a clue as to why RA patients produce inappropriate quantities of TNF. [13] [14] [15] The association between TNF microsatellites and TNF production phenotype has provided evidence for a contribution of the TNF gene itself to TNF production variability. 16 Since TNF microsatellites themselves are not likely to affect TNF production, they might be markers for functional relevant TNF gene polymorphisms.
Analysis of the segregation of five TNF microsatellite markers with disease in multicase RA families provided evidence for the presence of a susceptibility gene in or nearby the TNF locus independent of HLA-DRB1. 17 The search for genetic heterogeneity within the TNF gene uncovered several polymorphisms.
18-24 Two of the poly-morphisms in the promoter region of the TNF gene, at position −238 and −308 have been studied for functional relevance. The −238 polymorphism was shown to be nonfunctional in promoter/reportergene studies. 25, 26 Studies on the functional relevance of the TNF −308 polymorphism revealed conflicting results. 19, [27] [28] [29] [30] Disease association studies revealed that these polymorphisms do not contribute to disease susceptibitity in RA. 31, 32 However, disease stratification studies pointed to a role for the −238 promoter polymorphisms in disease severity. 32, 33 In this study we investigated the relation of the G to A transition polymorphism at position +489 in the first intron of the TNF gene 34 in susceptibility to and outcome of RA. We demonstrate that the TNF +489 A variant is associated with a decreased risk of developing RA independent of SE. Moreover, this gene variant is associated with less severe disease progression.
Results
Association of the TNF +489 polymorphism with RA The distribution of the TNF +489 alleles was analyzed in a group of 293 consecutive RA patients of the rheumatology outpatient clinic (RA group 1), a group of 99 RA patients who were followed for 12 years (RA group 2) and in a group of 138 healthy controls ( Figure 1 , Table  1 ). The frequency of the TNF +489 A allele was decreased in both RA group 1 (frequency = 6.8%, OR = 0.54, 95% CI 0.32-0.90, P = 0.0115) and RA group 2 (frequency = 7.1%, OR = 0.56, 95% CI 0.28-1.12, P = 0.08) compared to the control group (frequency = 12%). These data suggest that the +489 A allele has a protective effect on the development of RA. Since HLA-DRB1 alleles are known to be associated with RA, we analyzed the relation between the TNF +489 polymorphism and the disease-associated shared epitope (SE) containing HLA-DR1, -DR4 and -DR10 alleles in RA patients. In 229 RA patients of RA group 1, HLA-DR typing was available (Table 2 ). This analysis revealed no significant association between TNF +489 (P = 0.3) and any of the RA-associated DRB1 alleles, ie DRB1*01, DRB1*04 and DRB1*10. In addition, a similar percentage of SE heterozygous (+/−), homozygous (+/+) and SE negative (−/−) was found in RA patients with genotype TNF +489 AA/GA compared to RA patients with TNF genotype +489 GG. Thus the protective effect of the +489A allele is independent of the SE alleles.
Association of TNF +489 polymorphism with disease severity in RA In RA group 1 we determined whether an association exists between TNF +489 genotypes and clinical para- meters which reflect disease heterogeneity. This group of RA patients consisted of three patients with genotype TNF +489 AA, 34 TNF +489 GA patients and 256 TNF +489 GG patients. No significant differences in sex, age, duration of disease and duration of complaints were observed between the GA-typed and the GG-typed patients (Table 3) . However, patients with the +489 GA genotypes had a 3.9 times decreased chance of having erosive disease than the patients with the +489 GG genotype (OR = 3.9, 95% CI 1.33-11.55, P = 0.02). When we adjusted for SE positivity (OR = 5.05, 95% CI 1.44-17.70, P = 0.012), or rheumatoid factor positivity (OR 5.63, 95% CI 1.35-23.48, P = 0.018) a similar association was found. Adjustment for both SE, rheumatoid factor or duration of disease gave a similar risk (OR 5.07, 95% CI 1.14-22.57, P = 0.033). The observed association of TNF +489 A allele with milder disease could not be explained by linkage with any of the RA-associated DR1, DR4 and DR10 alleles.
Joint damage in relation to TNF +489 polymorphism in a prospective cohort of RA patients For RA group 2, disease progression was monitored during a period of 12 years. Only one patient was typed TNF +489 AA and was not included in the analysis. In Table  4 no significant differences in duration of complaints, SEpositivity and rheumatoid factor positivity were observed in the 98 patients studied (Table 4a ). The median radiographic damage score, expressed as Sharp score for X-ray of hands and feet, for the TNF +489 GA patients (n = 12) was 0 at onset of disease and developed to 10 at 3 years, 14 at 6 years and 40.5 at 12 years. For the TNF +489 GG (n = 86) patients, the Sharp score was 0 at onset and increased to 34 at 3 years, 65.5 at 6 years and 145 at 12 years. In the aggregate the progression rate was 3.4 per year for TNF +489 GA and 12.1 per year for TNF +489 GG patients. Analysis with repeated measures ANOVA revealed significant differences in the rate of joint damage (P = 0.05) (Table 4b ).
Discussion
In this study we demonstrate a significant decrease of the uncommon TNF +489 A allele in RA patients and a less severe disease course in RA patients carrying this allele. These data support the hypothesis that genes within or nearby the TNF/LT locus contribute to susceptibility to and severity of RA. The TNF +489 polymorphism, located in the first intron of the TNF gene, has only recently been described. 34 The frequency of the A allele of 12% in our control population of Dutch healthy individuals is in agreement with the distribution found in the British (15%) 35 and the Italian (14%) 34 population. The frequency is considerably lower in two independent groups of RA patients (respectively 6.8%, n = 293 and 7.1 %, n = 99). This association could not be explained by linkage with the SE alleles.
Usage of TDT testing to perform family-based association analysis revealed that the TNF/LT region appears to influence susceptibility to RA distinct from HLA-DRB1. 17 That study demonstrated that the TNF a6, b5, c1, d3, e3 (H1) microsatellite haplotype was strongly associated with affected individuals and showed skewed transmittance to affected offspring. Moreover, the TNF a6 and c1 alleles were individually associated with RA. It was suggested that the H1 haplotype synergizes with the SE alleles in RA susceptibility. A similar association was reported by Hajeer and coworkers 36 who found that the TNF a6 allele was significantly increased in RA. However, in that study the association appeared to be due to linkage disequilibrium with HLA-DRB1. In our study we found no evidence for linkage disequilibrium between the +489 alleles and the disease-associated SE alleles. A similar conclusion came from others who reported that the +489 polymorphism is not in linkage with HLA class II alleles associated with RA. 35, 37 Therefore, these results are in agreement with an independent contribution of the TNF/LT locus in RA susceptibility.
A retrospective analysis of consecutively selected RA patients from the outpatient clinic showed a significant association of the +489 GA genotype and less erosive disease in comparison to patients with the GG genotype. No alternative explanation could be found for this finding eg a difference in disease duration or in other predictors for progressive disease such as increased levels of rheuma-94 toid factor. Moreover the effect was independent from the HLA-DR1, DR4 and DR10-SE alleles, known to be differentially associated with disease severity. 6 In other words, the association of the TNF +489 A allele with milder disease is not secondary to a genetic linkage with DR1 alleles known to be involved with a less severe form of RA (Tables 2 and 3) . Similarly, the association of the TNF +489 G allele with a more severe course in RA is independent of DR4-homozygosity. Accordingly, in a prospective study of a well-defined cohort of RA patients who were followed for 12 years, the +489-GA patients developed significantly less joint damage than patients with the GG-genotype. Also in this group the currently known prognostic factors indicative for severe RA at first visit could not explain the difference in joint damage. Besides the +489 polymorphism, two other variants in the TNF/LT locus were reported to be associated with disease outcome in RA. First, the TNF a6 microsatellite was found to be more pronounced in patients with severe disease. 36 Secondly, the −238 polymorphism was found to be associated with erosive disease independent of HLA-DRB1. 25, 32 The association of the TNF +489 A allele with less erosive disease in RA was independent of the TNF −238 A allele. Thus the MHC class III locus may harbour susceptibility loci associated with disease severity in RA defined by TNF/LT markers.
In RA TNF is believed to be a pivotal mediator in the initiating phase of disease and disease persistence. 11 Transgenic mice that overexpress the human TNF gene develop arthritis resembling RA in man. 38 Physical blockade of TNF in patients is extremely successful in ameliorating RA. 12 Hence, variations in the capacity to produce TNF may be related to susceptibility and outcome of autoimmune and infectious diseases. The associations of TNF −238 alleles with disease outcome in other diseases like psoriasis and psoriatic arthritis, 39 SLE, 37 scarring thrachoma 40 and alcoholic steatohepatitis 41 has strengthened the speculation of functionality of TNF gene polymorphisms. However, functional analysis of the −238 polymorphism has not provided evidence for functional relevance of this TNF gene variant. 25, 26 Mullighan and coworkers reported on an association of the TNF +489 A allele in a subgroup of Common Variable Immune Deficiency patients characterized by distinct clinical features, particularly granulatoma formation and splenomegaly, independent of HLA. 35 These authors discussed the possibility that the TNF +489 A allele may be associated with increased TNF production. However, the protective effect in RA might preferentially be explained by a reduced production capacity of the +489 A allele. Likewise the biological explanation of the disease associations remains to be established. Preliminary data on the functional relevance of the +489 polymorphism by allele-specific transcript quantification analysis suggest no transcriptional difference between the TNF +489 A and TNF +489 G allele (Kaijzel EL, van Krugten MV, Verweij CL, unpublished observations). Thus the disease associations may have to be explained by linkage disequilibrium with alleles within or nearby the TNF/LT locus. Interestingly, preliminary data suggest a negative linkage disequilibrium between the +489 A allele and TNF a6 microsatellite, which might indicate that +489 G is part of the TNF a6 involved haplotype. Collectively, the data suggest that the intron polymorphism +489 A is part of an haplotype that is associated with less severe disease in RA and so probably associated with less TNF production in the joint.
Patients and methods
Rheumatoid arthritis patients and healthy controls: Two different groups of RA patients have been used. RA group 1: 293 consecutive patients from the rheumatology outpatient clinic as described in Brinkman et al. 32 The distribution of the TNF +489 alleles was determined in these patients who attended the outpatient clinic of the Leiden University Medical Centre in 1994. All patients fulfilled the American College of Rheumatology criteria of 1987 for RA. 42 To compare the distribution of the TNF +489 alleles in RA patients, 138 unrelated healthy blood donors were used as controls.
Case control study in RA group 1 patients: A case control study was performed to determine the relationship between the TNF +489 genotypes and disease severity. Control RA patients were selected by age and sex to obtain matched groups for the genotypes. Thirty-four individuals with the TNF +489 GA genotype and 256 individuals with the +489 GG genotype were included in the analysis. Since only three patients were homozygous +489 A, these patients were not included in the analysis. Data regarding the patients were collected from patient files and patient questionnaires. The following variables were documented: disease duration in years from diagnosis, duration of joint complaints in years, presence or absence of radiographically determined erosions in any X-ray made during disease course, as well as the number of erosive joints of the hands within the first 3 years of disease, presence or absence of rheumatoid nodules and presence or absence of increased serum levels of rheumatoid factor (RF). The health assessment questionnaire (HAQ) score was determined by patient questionnaires. 43 The number of joints affected by erosions in the hands within the first 3 years of the disease is an outcome variable that is associated with the time period between disease onset and the timepoint the X-rays were taken. To control for this variation, the time period between the onset of complaints, the moment of diagnosis and the date of the first radiograph in each group of patients with different TNF genotype was determined. No significant differences were observed between groups. The presence or absence of erosive disease is influenced by the number and timing of X-rays taken during the course of disease. This did not differ significantly between groups. Due to the retrospective design of the study, the analysis was restricted to parameters which are not, or to a very limited degree, influenced by secular trends.
RA group 2:
A cohort study of 138 consecutive incident female RA patients who were identified between 1982 and 1986 to enter a long-term follow-up study. 44 All patients fulfilled the 1958 criteria for definite RA. Three patients initially refused to cooperate and three patients were lost during the first years because of moving out of the area. Of the 132 patients who had a complete followup at 6 years, 45 112 patients could be completely assessed at an average follow-up of 12 years (range 10-14 years). Of the missing patients, three patients died, three refused and 14 were lost during follow-up. Disease progression was monitored at study entry and after 3, 6 and 12 years. At each visit radiographs were taken of hands and feet. The hands and feet radiographs were scored separately according to van der Heijde's modification of Sharp's method. 46 Radiographic X-rays of the hands and feet were scored in a modified way according to Sharp. Joint space narrowing, erosion and malalignment of 12 feet and 34 hand joints were scored. This method reflects erosions in 44 joints and joints-space narrowing in 42 joints. The principal measure, the total score, is the sum of erosion and narrowing scores, and ranges from 0 to 448. The X-rays were scored per patient, randomly through time.
DNA typing was performed on 99 out of the 112 RA patients. The missing data were caused by refusal of patients to visit the outpatient clinic, refusal to have genetic material tested and technical reasons. A detailed characteristic between the patients in which TNF genotypes were available (n = 99) and those not tested (n = 13) revealed no differences.
A panel of 138 random healthy blood donors from the Leiden university blood transfusion services was used as control group.
DNA isolation and HLA-DR typing DNA was isolated from 10 ml heparinized blood from each patient. Red cells were lysed and the remaining cells were incubated for 17 h at 37°C with SDS and proteinase K. The DNA was extracted using phenol and chloroform as described by Maniatis et al. 47 HLA-DR typing was performed as described by Verduyn et al. 48 Polymerase chain reaction: Genomic DNA from all individuals was amplified by the polymerase chain reaction (PCR). PCR was performed in 40-l reactions containing 100 ng of DNA, 10 pmol of each primer and 0.8 units of Taq polymerase. The temperature cycles were 1.5 min at 95°C, 2.5 min at 60°C and 1 min at 72°C for 35 cycles in a Perkin Elmer cycler 480 (PE-Cetus, Norwalk, CA, USA). An elongation time of 7 min at 72°C was used in the final cycle. Primers used in the PCR reaction, synthesized by Isogen Inc (Maarssen, The Netherlands), were as follows. Primer A (sense): −925; 5Ј TGTGACCACAGCAATGG GTA 3Ј, primer B (antisense) +668; 5Ј CCCACATCTTGTCTCCA-TATC 3Ј. Allele-specific DNA hybridization: The TNF +489 polymorphism could be detected in a DNA fragment from position −925 till +668 that was amplified by PCR using primer A and B. PCR products were dotblotted on Hybond N + membranes and hybridized as described by Verduyn et al. 48 Sequences of the sequencespecific oligonucleotides and their respective critical washing temperatures are shown in Table 5 . Autoradiography of TNF hybridization of TNF PCR-fragments with allele-specific TNF probes is shown in Figure 1 . Table 5 Sequences and critical washing temperatures of the biotinlabelled sequence-specific oligonucleotides that were used in this study 
Statistical analysis
The association between the TNF +489 polymorphism and presence of RA and the presence of erosive disease was estimated using odds ratio (95% confidence interval). Adjustment for covariates was done by logistic regression. The difference between the +489 GA and the +489 GG group regarding the rate of joint damage as judged by the Sharp score was analyzed using mixedmodel ANOVA. Our hypothesis concerned the association of the TNF +489 polymorphism with susceptibility and erosive disease, involving only one statistical test (per population). We therefore, decided that no adjustment for multiple testing was required. The other tests were only performed in an attempt to exclude alternative explanations for our finding that the TNF +489 polymorphism is associated with susceptibility and erosive disease.
